Wolverine Peptide

Service Description

Treatment includes: Medical consultation Peptide: Wolverine (BPC-157 + TB-500) Pen kit for protocol administration Is a two-phase peptide protocol designed with a structured clinical approach and positioned for performance and recovery support. Phase 1: Adaptation (Weeks 1–4) This initial phase is designed to introduce the protocol in a controlled manner and prepare the system for continued use. Phase 2: Active Phase (Weeks 5–12) The second phase represents the core cycle, delivering the full protocol duration for sustained application. Total duration: 12 weeks A structured, clinically inspired two-phase system combining consistency and progression for optimized protocol delivery. Progression into Phase 2 is determined based on the individual response during Phase 1 and the results observed by the medical team, allowing for a safe and personalized continuation of the protocol. If the treatment needs to be discontinued based on medical recommendation, or if the expected response and results are not achieved during Phase 1, the patient will not be charged for Phase 2 of the protocol.